Prognosis of incidental left bundle branch block
Abbasin Zegard1, Osita Okafor1, Joseph de Bono2
1Department of Cardiology, Aston Medical Research Institute, Aston Medical School, Aston University, Birmingham B15 2TH, UK.
Insights
Cardiovascular magnetic resonance (CMR) risk-stratifies patients with incidental left bundle branch block (iLBBB). Abnormal CMR findings indicate poor outcomes, while normal findings suggest comparable survival to controls.
Area of Science:
- Cardiology
- Medical Imaging
Background:
- Incidental left bundle branch block (iLBBB) frequently leads to cardiology referrals, often with prognostic uncertainty.
- Current risk stratification methods for iLBBB lack definitive prognostic value.
Purpose of the Study:
- To assess the utility of cardiovascular magnetic resonance (CMR) in risk stratification for patients with iLBBB.
- To determine if CMR can differentiate prognosis in patients with iLBBB.
Main Methods:
- A cohort of 193 patients with iLBBB underwent CMR.
- Patients were categorized into abnormal (iLBBBCMR+) or normal (iLBBBCMR-) CMR phenotypes.
- Clinical events were tracked over a median of 3.75 years, with outcomes compared to a control group (n=107).
Main Results:
- 56.9% of iLBBB patients had an abnormal CMR phenotype (iLBBBCMR+).
- iLBBBCMR+ patients exhibited significantly higher total mortality and major adverse cardiac events (MACEs) compared to controls.
- iLBBBCMR- patients had similar total mortality to controls but increased MACEs.
- Myocardial fibrosis and left ventricular ejection fraction (LVEF) ≤50% were independent predictors of mortality in iLBBB patients, with a combined additive effect.
Conclusions:
- Patients with iLBBB and abnormal CMR findings (iLBBBCMR+) face poor outcomes.
- Patients with iLBBB and normal CMR findings (iLBBBCMR-) have survival comparable to controls, though MACE risk is elevated.
- CMR is crucial for risk-stratifying iLBBB patients, identifying those at higher risk who may benefit from further intervention.
Aims:
Incidental left bundle branch block (iLBBB) is a frequent cause for cardiology referrals. In such instances, there is uncertainty as to its prognosis. We sought to determine the utility of cardiovascular magnetic resonance (CMR) in the risk stratification of patients with iLBBB.
Methods And Results:
Clinical events were collected in patients with iLBBB who had CMR. Controls had no cardiac symptoms or cardiac disease, a normal CMR scan and electrocardiogram. Amongst patients with iLBBB [n = 193, aged 62.7 ± 12.6 years (mean ± SD)], 110/193 (56.9%) had an abnormal phenotype (iLBBBCMR+) and 83/110 (43.0%) had a normal phenotype (iLBBBCMR-). Over 3.75 years (median; inter-quartile range: 2.7-5.5), iLBBBCMR+ had a higher total mortality [adjusted hazard ratio (aHR) 6.49, 95% confidence interval (CI) 1.91-22.0] and total mortality or major adverse cardiac events (MACEs; aHR 9.15, 95% CI 2.56-32.6) than controls (n = 107). In contrast, iLBBBCMR- had a similar risk of total mortality compared with controls, but total mortality or MACEs was higher (aHR 4.24, 95% CI 1.17-15.4; P = 0.028). Amongst iLBBB patients, both myocardial fibrosis (aHR 5.15, 95% CI 1.53-17.4) and left ventricular ejection fraction (LVEF) ≤ 50% (aHR 3.88, 95% CI 1.67-9.06) predicted total mortality. Myocardial fibrosis plus LVEF ≤50% was associated with the highest risk of total mortality (aHR: 9.87, 95% CI 2.99-32.6) and total mortality or MACEs (aHR 3.98, 95% CI 1.73-9.11).
Conclusions:
Outcomes in iLBBBCMR+ were poor whereas survival in iLBBBCMR- was comparable with controls. Myocardial fibrosis and LVEF <50% had an additive effect on the risk of clinical outcomes. A CMR scan is pivotal in risk-stratifying patients with iLBBB.
More Related Videos
13:10Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery ALCAPA
Published on: April 24, 2017
10:46Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology
Published on: May 26, 2015
Related Concept Videos
Dysrhythmias IV: Characteristics of Bradyarrhythmias
Mitral Stenosis II: Clinical features and Diagnostic Tests
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Mitral Stenosis I: Introduction
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Mitral Regurgitation II: Clinical Features and Diagnostic Tests
